Answers are grounded in this paper and cite their sources.
Evaluates the efficacy of prussian blue nanoplatforms in combatting multidrug-resistant bacterial infections, suggesting innovative treatment options.
The increasing crisis of multidrug-resistant (MDR) bacterial infections necessitates the development of advanced antimicrobial platforms with enhanced specificity and therapeutic efficacy. Prussian blue (PB) and its analogues have emerged as...
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: